학술논문

Durvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2017, 28 1p. Supplement: 5
Subject
Language
English
ISSN
15698041